<DOC>
	<DOC>NCT01548846</DOC>
	<brief_summary>This is a study whose main objective is to evaluate prospectively the proportion of patients with severe xerostomia one year after treatment with tomotherapy for head and neck cancer.</brief_summary>
	<brief_title>Impact of Tomotherapy on Xerostomia and Quality of Life of Patients With Cancer of the Upper Aero-digestive Tract</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>Patient (e) old (e) over 18 years Patients with squamous cell carcinoma of head and neck (oral cavity, oropharynx, lymphadenopathy without gateway) histologically proven. Patient targeted for head and neck radiotherapy by Tomotherapy exclusive with or without concurrent chemotherapy (containing platinum) Indication of head and neck radiotherapy bilateral All of the TNM stage except metastatic Patient has signed informed consent for participation in the study Mastery of the French language History of head and neck radiotherapy Indication of head and neck radiotherapy unilateral Personal history of malignant tumors uncontrolled over the past 5 years History of oral sicca syndrome Surgical removal of one or more salivary glands (parotid, submandibular gland, sublingual gland) Concomitant treatment with amifostine Concomitant treatment with cetuximab Primary tumor of the salivary glands Head and neck hyperfractionated radiotherapy and / or accelerated Head and neck radiotherapy hypofractionated Metastatic disease Patient deprived of liberty, under guardianship Any medical condition or psychological associate that could compromise the patient's ability to participate in the study Refusal of the patient.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>tomotherapy</keyword>
	<keyword>xerostomy</keyword>
	<keyword>head and neck squamous cell carcinoma</keyword>
</DOC>